Novel Tricyclic Inhibitors Of Ikk2: Discovery And Sar Leading To The Identification Of 2-Methoxy-N-((6-(1-Methyl-4-(Methylamino)-1,6-Dihydroimidazo[4,5-D]Pyrro Lo[2,3-B]Pyridin-7-Yl)Pyridin-2-Yl)Methyl)Acetamide (Bms-066)

Bioorganic & Medicinal Chemistry Letters(2011)

Cited 12|Views14
No score
Abstract
The synthesis, structure-activity relationships (SAR), and biological results of pyridyl-substituted azaindole based tricyclic inhibitors of IKK2 are described. Compound 4m demonstrated potent in vitro potency, acceptable pharmacokinetic and physicochemical properties, and efficacy when dosed orally in a mouse model of inflammatory bowel disease. (C) 2011 Elsevier Ltd. All rights reserved.
More
Translated text
Key words
IKK, IKK2, IKK beta, NF-kappa B, BMS-066
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined